Literature DB >> 21191021

Reversal of heterochromatic silencing of quiescent herpes simplex virus type 1 by ICP0.

Michael W Ferenczy1, Neal A DeLuca.   

Abstract

Persisting latent herpes simplex virus genomes are to some degree found in a heterochromatic state, and this contributes to reduced gene expression resulting in quiescence. We used a relatively long-term quiescent infection model in human fibroblasts, followed by provision of ICP0 in trans, to determine the effects of ICP0 on the viral chromatin state as gene expression is reactivated. Expression of ICP0, even at low levels, results in a reduction of higher-order chromatin structure and heterochromatin on quiescent viral genomes, and this effect precedes an increase in transcription. Concurrent with transcriptional activation, high levels of ICP0 expression result in the reduction of the heterochromatin mark trimethylated H3K9, removal of histones H3 and H4 from the quiescent genome, and hyperacetylation of the remaining histones. In contrast, low levels of ICP0 did not appreciably change the levels of histones on the viral genome. These results indicate that ICP0 activity ultimately affects chromatin structure of quiescent genomes at multiple levels, including higher-order chromatin structure, histone modifications, and histone association. Additionally, the level of ICP0 expression affected its ability to change chromatin structure but not to reactivate gene expression. While these observations suggest that some of the effects on chromatin structure are possibly not direct, they also suggest that ICP0 exerts its effects through multiple mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21191021      PMCID: PMC3067893          DOI: 10.1128/JVI.02263-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival.

Authors:  W E Hobbs; D E Brough; I Kovesdi; N A DeLuca
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  ICP0 induces the accumulation of colocalizing conjugated ubiquitin.

Authors:  R D Everett
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Binding of ICP4, TATA-binding protein, and RNA polymerase II to herpes simplex virus type 1 immediate-early, early, and late promoters in virus-infected cells.

Authors:  Padmavathi Sampath; Neal A Deluca
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

4.  Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro.

Authors:  Chris Boutell; Seth Sadis; Roger D Everett
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency.

Authors:  W P Halford; P A Schaffer
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.

Authors:  A J Bannister; P Zegerman; J F Partridge; E A Miska; J O Thomas; R C Allshire; T Kouzarides
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

7.  ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells.

Authors:  W P Halford; C D Kemp; J A Isler; D J Davido; P A Schaffer
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

8.  The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a.

Authors:  Haidong Gu; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-10       Impact factor: 11.205

9.  The herpes simplex virus type 1 ICP0 promoter is activated by viral reactivation stimuli in trigeminal ganglia neurons of transgenic mice.

Authors:  C M Loiacono; N S Taus; W J Mitchell
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

10.  Specific histone tail modification and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression.

Authors:  Nicole J Kubat; Robert K Tran; Peterjon McAnany; David C Bloom
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more
  27 in total

1.  Herpes simplex virus 1 ICP0 phosphorylation site mutants are attenuated for viral replication and impaired for explant-induced reactivation.

Authors:  Heba H Mostafa; Thornton W Thompson; Anna S Kushnir; Steve D Haenchen; Adam M Bayless; Joshua G Hilliard; Malen A Link; Lisa A Pitcher; Emma Loveday; Priscilla A Schaffer; David J Davido
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity.

Authors:  Yoshitaka Miyagawa; Pietro Marino; Gianluca Verlengia; Hiroaki Uchida; William F Goins; Shinichiro Yokota; David A Geller; Osamu Yoshida; Joseph Mester; Justus B Cohen; Joseph C Glorioso
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

3.  Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression.

Authors:  Fang Han; Yoshitaka Miyagawa; Gianluca Verlengia; Selene Ingusci; Marie Soukupova; Michele Simonato; Joseph C Glorioso; Justus B Cohen
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

4.  Requirement of the N-terminal activation domain of herpes simplex virus ICP4 for viral gene expression.

Authors:  Lauren M Wagner; Avraham Bayer; Neal A Deluca
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

5.  Functional characterization of residues required for the herpes simplex virus 1 E3 ubiquitin ligase ICP0 to interact with the cellular E2 ubiquitin-conjugating enzyme UBE2D1 (UbcH5a).

Authors:  Emilia Vanni; Derek Gatherer; Lily Tong; Roger D Everett; Chris Boutell
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

6.  Activities of ICP0 involved in the reversal of silencing of quiescent herpes simplex virus 1.

Authors:  Michael W Ferenczy; Daniel J Ranayhossaini; Neal A Deluca
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

7.  Herpes simplex virus 1 DNA is in unstable nucleosomes throughout the lytic infection cycle, and the instability of the nucleosomes is independent of DNA replication.

Authors:  Jonathan J Lacasse; Luis M Schang
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

8.  Transcription of the herpes simplex virus 1 genome during productive and quiescent infection of neuronal and nonneuronal cells.

Authors:  Justine M Harkness; Muhamuda Kader; Neal A DeLuca
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

9.  Novel roles of cytoplasmic ICP0: proteasome-independent functions of the RING finger are required to block interferon-stimulated gene production but not to promote viral replication.

Authors:  Kathryne E Taylor; Marianne V Chew; Ali A Ashkar; Karen L Mossman
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

10.  Nuclear interferon-inducible protein 16 promotes silencing of herpesviral and transfected DNA.

Authors:  Megan H Orzalli; Sara E Conwell; Christian Berrios; James A DeCaprio; David M Knipe
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.